The Global Market for Insomnia: Trends, Forecasts, and Competitive Analysis to 2030 Featuring Vanda Pharma, Neurim, Eisai, Purdue Pharma, Merck, Pfizer, Astellas, Flynn Pharma, Takeda Phar...
Vanda Pharmaceuticals Inc. (VNDA)
Last vanda pharmaceuticals inc. earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=196233&p=irol-irhome
Company Research
Source: Yahoo! Finance
The global insomnia market is expected to reach an estimated $5.1 billion by 2030 with a CAGR of 3.6% from 2024 to 2030. The major drivers for this market are growing prevalence of different types of sleep disorders like insomnia and parasomnias, expanding insurance coverage for insomnia treatments, and increasing government initiatives to support sleep insomnia treatment. The future of the market looks promising with opportunities in the capsule and tablet markets. This study includes a forecast for the global insomnia by type of therapy, drug formulation, type of disease, and region. Insomnia Market by Type of Therapy [Shipment Analysis by Value from 2018 to 2030]: Pharmacological Therapy Non-Pharmacological Therapy Insomnia Market by Drug Formulation [Shipment Analysis by Value from 2018 to 2030]: Capsules Tablets Others Insomnia Market by Type of Disease [Shipment Analysis by Value from 2018 to 2030]: Poor Quality of Sleep Sleep Maintenance Others Insomnia
Show less
Read more
Impact Snapshot
Event Time:
VNDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VNDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VNDA alerts
High impacting Vanda Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
VNDA
News
- Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals [Yahoo! Finance]Yahoo! Finance
- Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda PharmaceuticalsGlobeNewswire
- Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Vanda (VNDA) to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]Yahoo! Finance
- Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation [Yahoo! Finance]Yahoo! Finance
VNDA
Earnings
- 2/7/24 - Beat
VNDA
Analyst Actions
- 2/9/24 - TheStreet
VNDA
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEF
- 4/17/24 - Form 8-A12B
- VNDA's page on the SEC website